⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2948039 | 0.95 | — | — | |
| SCHEMBL4042916 | 0.91 | — | — | |
| Hydrochloric Acid SCHEMBL20293396 | 0.87 | — | — | |
| SCHEMBL352244 | 0.87 | — | — | |
| SCHEMBL1830968 | 0.83 | TSHR (0.41) | — | |
| SCHEMBL9801578 | 0.83 | — | — | |
| SCHEMBL1833697 | 0.83 | TSHR (0.41) | — | |
| SCHEMBL208999 | 0.83 | — | — | |
| Hydrochloric Acid SCHEMBL2483713 | 0.80 | — | — | |
| SCHEMBL20327006 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12036192-B2 | Combination treatments for opioid crisis | PRESTI MICHAEL (US) | 2024-07-16 | — | — | US | claimed |
| WO-2023177841-A2 | COMBINATION PRODUCTS TO MITIGATE MISUSE OF CENTRAL NERVOUS SYSTEM STIMULANTS | PRESTI MICHAEL (US) | 2023-09-21 | — | — | WO | claimed |
| CN-115084519-A | Lithium iron phosphate system slurry and preparation method and application thereof | 蜂巢能源科技(无锡)有限公司 | 2022-09-20 | — | — | CN | claimed |
| WO-2022086835-A1 | COMBINATION PRODUCTS TO MITIGATE THE RISK OF NON-BENZODIAZEPINE BENZODIAZEPINE AGONIST ADVERSE REACTION AND OVERDOSE | PRESTI MICHAEL (US) | 2022-04-28 | — | — | WO | claimed |
| US-20220117916-A1 | Combination Products to Mitigate the Risk of Non-Benzodiazepine Benzodiazepine Agonist Adverse Reaction and Overdose | SAFERX PHARMACEUTICALS LLC (US) | 2022-04-21 | — | — | US | claimed |
| US-20220000809-A1 | Combination Treatments for Opioid Crisis | PRESTI MICHAEL (US) | 2022-01-06 | — | — | US | claimed |
| CN-113456635-A | Ciclopirox olamine cream and preparation method thereof | 海南海神同洲制药有限公司 | 2021-10-01 | — | — | CN | claimed |
| US-20210161835-A1 | Combination Treatments for Opioid Crisis | PRESTI MICHAEL (US) | 2021-06-03 | — | — | US | claimed |
| US-10881625-B2 | Combination treatments for opioid crisis | PRESTI MICHAEL (US) | 2021-01-05 | — | — | US | claimed |
| EP-3743073-A1 | COMBINATION TREATMENTS FOR OPIOID CRISIS | Presti, Michael (US) | 2020-12-02 | — | — | EP | claimed |
| WO-2013116721-A1 | RETINALDEHYDE MIMETICS AND INHIBITORS OF RETINALDEHYDE DEHYDROGENASE I IN THE TREATMENT OF DISORDERS | THE BRIGHAM AND WOMEN'S HOSPTIAL, INC. (US) | 2013-08-08 | — | — | WO | claimed |
| EP-2611440-A1 | TREATMENT FOR COCAINE ADDICTION | Tonix Pharmaceuticals, Inc. (US) | 2013-07-10 | — | — | EP | claimed |
| US-20130165511-A1 | TREATMENT FOR COCAINE ADDICTION | TONIX Pharmaceuticals Holding Corp (US) | 2013-06-27 | — | — | US | claimed |
| WO-2012050594-A1 | TREATMENT FOR COCAINE ADDICTION | Tonix Pharmaceuticals, Inc. (US) | 2012-04-19 | — | — | WO | claimed |
| EP-1441708-B1 | COMPOSITIONS AND METHODS FOR INCREASING COMPLIANCE WITH THERAPIES USING ALDEHYDE DEHYDROGENASE INHIBITORS AND TREATING ALCOHOLISM | KRELE PHARMACEUTICALS LLC (US) | 2009-04-08 | — | — | EP | claimed |
| US-20090005441-A1 | COMPOSITIONS AND METHODS FOR INCREASING COMPLIANCE WITH THERAPIES USING ALDEHYDE DEHYDROGENASE INHIBITORS AND TREATING ALCOHOLISM | KRELE PHARMACEUTICALS, INC. (US) | 2009-01-01 | — | — | US | claimed |
| EP-1441708-A4 | COMPOSITIONS AND METHODS FOR INCREASING COMPLIANCE WITH THERAPIES USING ALDEHYDE DEHYDROGENASE INHIBITORS AND TREATING ALCOHOLISM | KRELE PHARMACEUTICALS LLC (US) | 2007-05-23 | — | — | EP | claimed |
| EP-1441708-A1 | COMPOSITIONS AND METHODS FOR INCREASING COMPLIANCE WITH THERAPIES USING ALDEHYDE DEHYDROGENASE INHIBITORS AND TREATING ALCOHOLISM | Krele Pharmaceuticals LLC (US) | 2004-08-04 | — | — | EP | claimed |
| WO-2003039525-A1 | COMPOSITIONS AND METHODS FOR INCREASING COMPLIANCE WITH THERAPIES USING ALDEHYDE DEHYDROGENASE INHIBITORS AND TREATING ALCOHOLISM | KRELE PHARMACEUTICALS LLC (US) | 2003-05-15 | — | — | WO | claimed |
| US-20030087814-A1 | Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism | KRELE PHARMACEUTICALS, INC. | 2003-05-08 | — | — | US | claimed |